pillbase.ru

Exenatide

Active substance: exenatide

INJECTION · EXENATIDE 250 ug/mL

United StatesActive

Marketing holder: Amneal Pharmaceuticals LLC

Verified 2026-10-09 · openFDA NDC

Analogues in other countries
Composition
Analogues by country

Products with the same active substance registered in other countries.

CountryProducts
RU 2
  • Баета®
    раствор для подкожного введения, 250 мкг/мл, 2.4 мл (original in Russian, GRLS)
    ЛС-002221
    АстраЗенека ЮК Лимитед
  • Баета® Лонг
    порошок для приготовления суспензии для подкожного введения пролонгированного действия, 2 мг, 2 мг (original in Russian, GRLS)
    ЛП-004205
    АстраЗенека ЮК Лимитед
EU 2
  • Bydureon
    exenatide
    EMEA/H/C/002020
    AstraZeneca AB
  • Byetta
    exenatide
    EMEA/H/C/000698
    AstraZeneca AB
Import and control

Control by country

  • Russiaprescription only

    Source: GRLS (Russian state register) · record 01a120c4-b952-7a42-a686-fc31d7987ca6,01a120c5-51ec-752f-972d-c1ccc04bf18a;count=2 · valid from 2026-10-09 · verified 2026-10-09

  • United Statesprescription only

    Source: openFDA NDC · record 01a1208d-a0ab-71e2-a58e-ebbcf88f7360,01a12090-7dfb-797b-9a8a-b80190281e02,01a12090-7e0a-7105-8266-8abc3191ec00,01a12099-72ff-7518-93e9-b73356d45ee1;count=4 · valid from 2026-10-09 · verified 2026-10-09

More on control status
Registration
Registration number
70121-1686
Registration status
Active
Dispensing
Prescription only
Route
SUBCUTANEOUS
Sources
  • product · openFDA NDC · 70121-1686 · Verified 2026-10-09 · open in source
  • registration_status · openFDA NDC · 70121-1686 · Verified 2026-10-09 · open in source
  • ingredients.0 · openFDA NDC · 70121-1686 · Verified 2026-10-09 · open in source